10.3
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
View the full transcript and gain access to JoVE Core videos
Q1: How do Class I antiarrhythmic drugs work to treat irregular heart rhythms?
Class I antiarrhythmic drugs block open or inactivated voltage-sensitive sodium channels in continuously depolarizing cardiac tissues. By reducing sodium ion influx, they prevent auto-excitation and hinder action potential propagation, thereby restoring normal cardiac function and treating dysrhythmias.
Q2: What are the key differences between Class IA, IB, and IC antiarrhythmic drugs?
Class IA drugs have intermediate dissociation kinetics, slow phase 0 depolarization, and block potassium channels to prolong the refractory period. Class IB drugs exhibit fast dissociation kinetics and shorten action potential duration. Class IC drugs possess slow dissociation kinetics and significantly reduce phase 0 depolarization without affecting action potential duration.
Q3: Why do Class IB antiarrhythmic drugs work well for treating ventricular arrhythmias after heart attacks?
Class IB drugs like lidocaine preferentially target ischemic or depolarized tissues and have minimal effects on healthy cardiac tissue. They decrease action potential duration and accelerate repolarization, making them particularly useful for treating ventricular arrhythmias associated with acute myocardial infarction.
Q4: What effects do Class IA drugs have on the cardiac action potential and refractory period?
Class IA drugs block potassium channels in addition to sodium channels, which prolongs both the refractory period and action potential duration. They also slow phase 0 depolarization through their intermediate dissociation kinetics from sodium channels, affecting overall cardiac conduction velocity.
Q5: What are the main side effects and safety concerns with Class I antiarrhythmic drugs?
All Class I drugs are proarrhythmic and can cause delayed conduction, tachycardia, and negative inotropy. Common side effects include dizziness and visual disturbances. Class IA drugs may cause drug-induced lupus or QT interval prolongation. Dosage adjustments are necessary for patients with liver or renal dysfunction.
Q6: How do Class IC drugs differ from other Class I agents in their effects on cardiac conduction?
Class IC drugs like flecainide and propafenone have potent sodium channel-blocking effects with slow dissociation kinetics. They significantly slow conduction velocity without affecting action potential duration or repolarization phase, distinguishing them from Class IA and IB agents that alter these parameters.
Q7: How do Class I antiarrhythmic drugs compare to other antiarrhythmic drug classes?
Class I drugs block sodium channels, while antiarrhythmic drugs class iii agents as potassium channel blockers work through different mechanisms. Understanding the distinctions between sodium, potassium, and calcium channel blockers helps clinicians select appropriate therapy based on arrhythmia type and patient factors.